Average Co-Inventor Count = 7.39
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (11 from 3,685 patents)
2. Innate Tumor Immunity, Inc. (4 from 21 patents)
15 patents:
1. 12338228 - NLRP3 modulators
2. 12187706 - NLRP3 modulators
3. 12171756 - NLRP3 modulators
4. 11344543 - NLRP3 modulators
5. 10174024 - 5H-pyrido[3,2-B]indole compounds as anticancer agents
6. 9751879 - Tricyclic compounds as anticancer agents
7. 9492460 - Carbazole compounds useful as bromodomain inhibitors
8. 9427442 - Fluoroalkyl and fluorocycloalkyl 1,4-benzodiazepinone compounds
9. 9273014 - Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof
10. 9242940 - N-substituted bis(fluoroalkyl)-1,4-benzodiazepinone compounds
11. 9187434 - Substituted 1,5-benzodiazepinones compounds
12. 8999918 - Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof
13. 8148400 - Thiazolyl compounds useful as kinase inhibitors
14. 7456194 - [object Object]
15. 7176214 - Imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds and pharmaceutical compositions comprising same